Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3598471 | 0.82 | MGAM (0.44) | MGAMGAASIMGAM2 | |
| SCHEMBL706893 | 0.79 | — | — | |
| SCHEMBL706892 | 0.79 | — | — | |
| SCHEMBL13650458 | 0.79 | — | — | |
| SCHEMBL10771721 | 0.78 | SMN1; SMN2 (0.43) | MGAMGAASIMGAM2 | |
| SCHEMBL31424894 | 0.77 | ACHE (0.40) | MGAMGAASIMGAM2CHRNB2 | |
| SCHEMBL20222504 | 0.76 | TSHR (0.39) | MGAMGAASIMGAM2CHRNB2 | |
| SCHEMBL4392446 | 0.76 | — | — | |
| SCHEMBL18162798 | 0.76 | TSHR (0.39) | MGAMGAASIMGAM2CHRNB2 | |
| SCHEMBL16155384 | 0.75 | ALDH1A1 (0.48) | ZDHHC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5639770-A | SUPEROXIDE INHIBITOR | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1997-06-17 | — | — | US | disclosed |
| EP-0600092-A1 | THIAZOLE DERIVATIVE | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1994-06-08 | — | — | EP | disclosed |